Change in colony morphology influences the virulence as well as the biochemical properties of the Mycobacterium avium complex

Microbial Pathogenesis

Volumn 25, Issue 4, 1998, Pages 203-214

  Kansal, Rita G ^a   Gomez Flores, Ricardo ^a   Mehta, Reeta T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biochemical properties; Colony morphology; Growth rate; MTT reduction; Mycobacterium avium complex; Virulence

Indexed keywords

NEUTRAL RED; TETRAZOLIUM;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM COLONY; BACTERIUM MUTANT; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REDUCTION;

EID: 0031727168     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1998.0227     Document Type: Article

References (27)

1. Horsburgh CR Jr., Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Resp Dis 1989; 139: 4-7.
2. Macher AM, Kovacs JA, Gill V et al. Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodificiency syndrome. Ann Intern Med 1983; 99: 782-5.
3. Murray JF, Felton CP, Garay SM et al. Pulmonary complications of the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 1682-8.
4. Young LS. Mycobacterium avium complex infection. J Infect Dis 1988; 157: 863-7.
5. Pattyn SR, Hermans-Boveroulle MT. Dissociation in M. avium. Pneumonology 1970; 142: 119-25.
6. Inderlied CB, Kemper CA, Bermudez LE. The Mycobacterium avium complex. Clin Microbiol Rev 1993; 6: 266-310.
7. Benson CA. Treatment of disseminated disease due to M. avium complex in patients with AIDS. Clin Infect Dis 1994; 18(suppl 3): S237-42.
8. Pattyn SR. A study of group 111 non chromogenic mycobacteria. Correlation of chicken virulence with other in vitro characters among 20 strains. Zeitsch für Tuberk 1967; 127: 41-6.
9. Moehring JM, Solotorovsky MR. Relationship of colonial morphology to virulence for chickens of Mycobacterium avium and the non-photochromogens. American Review of Respiratory Disease 1965; 92: 704-13.
10. Schaefer WB, Davis CL, Cohn ML. Pathogenicity of transparent, opaque and rough variants of Mycobacterium avium in chickens and mice. Am Rev Resp Dis 1970; 102: 499-506.
11. Anz W, Meissner G. Comparative virulence test in chickens with transparent and opaque strains of avian mycobacteria of different serotypes. Zentralblatt Für Bakteriologie, Parasitenkunde, Infektionskranheiten Und Hygiene 1972; 221: 334-42.
12. Reddy VM, Luna-Herrera J, Gangadharam PRJ. Pathobiological significance of colony morphology in Mycobacterium avium complex. Microb Pathog 1996; 21:97-109.
13. Gangadharam PRJ. Beige mouse model for Mycobacterium avium complex disease. Antimicrob Agents Chemother 1995; 39: 1647-54.
14. Kuze F, Uchihira F. Various colony formers of Mycobacterium avium-intracellulare. Eur J Resp Dis 1984; 65: 402-10.
15. Pedrosa J, Florido M, Kunze ZM et al. Characterization of the virulence of Mycobacterium avium Complex (MAC) isolates in mice. Clin Exp Immunol 1994; 98: 210-16.
16. Mehta RT. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection. Antimicrob Agents Chemother 1996; 40: 1893-902.
17. Gomez-Flores R, Tucker SD, Kansal RG, Tamez-Guerra R, Mehta RT. Enhancement of antibacterial activity of clofazimine against Mycobacterium avium-intracellulare complex infection induced by IFN-γ is mediated by TNF-α. J Antimicrob Chemother 1997; 39: 189-97.
18. Kansal RG, Gomez-Flores R, Sinha I, Mehta RT. Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex in mice depends on size of initial inoculum and duration of infection. Antimicrob Agents Chemother 1997; 41: 17-23.
19. Gangadharam PRJ, Perumal VK, Jairam BT, Podapati R, Taylor RB, LeBrecque JF. Virulence of Mycobacterium avium complex strains from acquired immune deficiency syndrome patients: relationship with characteristics of the parasite and host. Microb Pathog 1989; 7: 263-78.
20. Reddy VM, Parikh K, Luna-Herrera J, Falkinham JO, Brown S, Gangadharam PRJ. Comparison of virulence of Mycobacterium avium complex (MAC) strains isolated from AIDS and non-AIDS patients. Microb Pathog 1994; 16: 121-30.
21. Toba H, Crawford JT, Ellner JJ. Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage activating factor activity of gamma interferon. Infect Immun 1989; 57: 239-44.
22. Crowle AJ, Tsang AY, Vatter AE, May MH. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol 1986; 24: 812-21.
23. Sarmento AM, Appelberg R. Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages. Infect Immun 1995; 63: 3759-64.
24. Sarmento AM, Appelberg R. Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium. Infect Immun 1996; 64: 3224-30.
25. Gomez-Flores R, Gupta S, Tamez-Guerra R, Mehta RT. Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method. J Clin Microbiol 1995; 33: 1842-6.
26. Plikaytis BB, Plikaytis BD, Yakrus MA et al. Differentiation of slowly growing Mycobacteria species, including Mycobacterium tuberculosis, be gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol 1992; 30: 1815-22.
27. Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of Mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993; 31: 175-8.